Work

Discrepancies in response and immune-related adverse events (irAE) of anti-PD-1 monotherapy between races and primary sites in patients (pts) with advanced nonacral cutaneous melanoma (NACM).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.9530

Authors: Xue Bai, Alexander Noor Shoushtari, Allison Betof Warner, Henry Quach, Christopher G Cann, Michael Zhang, Lalit Pallan, Catriona Harvey, Lu Si, Bixia Tang, Chuanliang Cui, Michelle S. Kim, Tatyana Sharova, Keith Flaherty, Georgina V. Long, Alexander M. Menzies, Ryan J. Sullivan, Genevieve Marie Boland, Douglas Buckner Johnson, Jun Guo

Institutions: Peking University Cancer Hospital, Memorial Sloan Kettering Cancer Center, Vanderbilt University Medical Center, Melanoma Institute Australia, Royal North Shore Hospital, Massachusetts General Hospital, Harvard University, Dana-Farber Cancer Institute, The University of Sydney

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170775707

Cites:

Cited by: 1

Related to: 10